دورية أكاديمية

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC

التفاصيل البيبلوغرافية
العنوان: NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC
المؤلفون: de Castro, Gilberto, Rizvi, Naiyer A., Schmid, Peter, Syrigos, Konstantinos, Martin, Claudio, Yamamoto, Nobuyuki, Cheng, Ying, Moiseyenko, Vladimir, Summers, Yvonne, Vynnychenko, Ihor, Lee, Sung Yong, Bryl, Maciej, Zer, Alona, Erman, Mustafa, Timcheva, Constanta, Raja, Rajiv, Naicker, Kirsha, Scheuring, Urban, Walker, Jill, Mann, Helen, Chand, Vikram, Mok, Tony
المصدر: Journal of Thoracic Oncology ; volume 18, issue 1, page 106-119 ; ISSN 1556-0864
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jtho.2022.09.223
الإتاحة: https://doi.org/10.1016/j.jtho.2022.09.223Test
https://api.elsevier.com/content/article/PII:S1556086422018238?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1556086422018238?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.E463543A
قاعدة البيانات: BASE